Company: OXBRW
Filing Date: 2025-07-10
Form Type: 424B5
Source: 0001641172-25-018473
Chunk: 11

Company: OXBRIDGE RE HOLDINGS Ltd
Filing Date: 2025-07-10
Form: 424B5
Chunk 11
---
| Ordinary                                              
 shares to be outstanding after this offering*         |     | 7,671,004                                                                                                                              
 ordinary shares (assuming no exercise of any ordinary share warrants).                                                                 |

*The number of our ordinary shares that will be outstanding immediately after this offering as shown above is based on 7,442,922 shares outstanding as of March 31. 2025, and a total of 228,082 ordinary shares sold in this offering (assuming a sale price of $2.27 per share, which was the closing price of our ordinary shares on The Nasdaq Capital Market on July 2, 2025). The number of shares outstanding as of March 31, 2025 as used throughout this prospectus supplement, unless otherwise indicated, excludes:

| ● | 376,250                                                                                                                    
 ordinary shares issuable upon the exercise of options outstanding at a weighted average exercise price of $6.01 per share; |

| ● | 66,912                                                                                                                                 
 ordinary shares issuable upon the vesting of restricted stock awards with a weighted-average grant date fair value of $4.13 per share; |

| ● | 687,514                                                                                       
 ordinary shares reserved for future issuance under our 2014 and 2021 Omnibus Incentive Plans; |

| ● | 1,411,768                                                                                                             
 ordinary shares issuable upon exercise of the ordinary share warrants, with an exercise price of $4.25 per share; and |

| ● | 8,230,700                                                                                                                          
 of our ordinary shares reserved for issuance upon exercise of our outstanding warrants, with an exercise price of $7.50 per share; |

| S-3 |

<div align='center'>Risk Factors</div>

An investment in our ordinary shares involves a high degree of risk. Prior to making a decision about investing in our securities, you should carefully consider the specific risk factors discussed below as well as the risk factors discussed under the sections entitled “Summary of Risk Factors” and “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and our subsequent Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings we make under the Exchange Act, each of which is incorporated by reference in this prospectus supplement in its entirety, together with all of the other information contained or incorporated by reference in this prospectus supplement and the accompanying prospectus, the documents incorporated by reference herein